Fate Therapeutics, Inc. earnings per share and revenue

FATE earnings per share for the last quarter are -0.44 USD whereas the estimation was -0.43 USD which accounts for -1.75% surprise. Company revenue for the same period amounts to 1.86 M USD despite the estimated figure of 1.37 M USD. Estimated earnings per share for the next quarter are -0.39 USD, and revenue is expected to reach 969.09 k USD. Also watch annual changes over time to get a bigger picture of FATE earnings per share and revenue dynamics.